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Abstract
Bipolar disorder (BD) is a common neuropsychiatric disorder characterized by chronic recurrent 
episodes of depression and mania. Despite evidence for high heritability of BD, little is known 
about its underlying pathophysiology. To develop new tools for investigating the molecular and 
cellular basis of BD we applied a family-based paradigm to derive and characterize a set of 12 
induced pluripotent stem cell (iPSC) lines from a quartet consisting of two BD-affected brothers 
and their two unaffected parents. Initially, no significant phenotypic differences were observed 
between iPSCs derived from the different family members. However, upon directed neural 
differentiation we observed that CXCR4 (CXC chemokine receptor-4) expressing central nervous 
system (CNS) neural progenitor cells (NPCs) from both BD patients compared to their unaffected 
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parents exhibited multiple phenotypic differences at the level of neurogenesis and expression of 
genes critical for neuroplasticity, including WNT pathway components and ion channel subunits. 
Treatment of the CXCR4+ NPCs with a pharmacological inhibitor of glycogen synthase kinase 3 
(GSK3), a known regulator of WNT signaling, was found to rescue a progenitor proliferation 
deficit in the BD-patient NPCs. Taken together, these studies provide new cellular tools for 
dissecting the pathophysiology of BD and evidence for dysregulation of key pathways involved in 
neurodevelopment and neuroplasticity. Future generation of additional iPSCs following a family-
based paradigm for modeling complex neuropsychiatric disorders in conjunction with in-depth 
phenotyping holds promise for providing insights into the pathophysiological substrates of BD and 
is likely to inform the development of targeted therapeutics for its treatment and ideally 
prevention.
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bipolar disorder; stem cell; iPSC; neurodevelopment; corticogenesis; neuroplasticity; calcium 
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INTRODUCTION
The precise relationship between the etiology and cellular pathophysiology of bipolar 
disorder (BD) remains poorly understood1–3. In light of its high heritability4,5, genome-wide 
association studies (GWAS) have been used to identify genes and pathways associated with 
BD risk. Several GWAS and their meta-analyses have reported several genomic loci that 
meet the criteria of genome-wide significance5–7. However, despite these genetic efforts the 
biological basis of BD remains elusive and the path toward highly effective, disease-
modifying, targeted therapeutics is uncertain. Measurable brain pathology has had limited 
success as well; consistent neuroanatomical deficits have been difficult to identify. Some of 
the most consistent imaging results have implicated grey matter changes in both emotion 
and reward processing circuits8. Anatomical deficits such as these brain volume changes 
have prompted some researchers to label BD a “neurodevelopmental” disorder, but the basis 
for such neurodevelopmental deficits has remained unclear. Other data that supports such a 
model implicate neural stem cell or neural progenitors. For instance, mutations in the DISC1 
gene have been associated with several forms of mental illness in an extended Scottish 
pedigree9, including BD10. DISC1 has been shown to regulate neural progenitor 
proliferation through inhibition of GSK3µ11, a known target of the mood stabilizer lithium 
signaling12–14. Furthermore antidepressant treatments have been shown to alter neural stem 
neurogenesis and plasticity. Thus, with what is proving to be a highly complex genetic 
landscape, modeling approaches investigating changes in single or small numbers of genes 
are incapable of capturing the full spectrum of factors that may impact pathophysiological 
process relevant to BD.
In light of the need to examine genetically associated loci across a developmental 
continuum, and implication of neural stem cell neurogenesis in mood regulation, cellular 
models that allow access to different developmental stages would be invaluable to the 
further study of mood disorders. Fortunately, recent advances in human stem-cell biology 
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now provide the technology to create genetically accurate, patient-derived cellular tools 
through the reprogramming of somatic cells to a pluripotent state. Multiple central nervous 
system (CNS) lineages, including neurons and glia, can be derived from iPSCs facilitating 
access to ex vivo characterization of patient-specific, cellular phenotypes that have otherwise 
been inaccessible15–17. Reflective of the increasing value of this strategy for human disease 
modeling, disease-specific, stem cell models have now been generated from multiple 
monogenic disorders using somatic cell reprogramming18–24. However, despite the potential 
for providing a basic human cellular model system and critically needed insight into the 
underlying pathophysiology, to date, only limited application of iPSC modeling has been 
performed in the context of complex genetic disorders25–28.
In the case of BD, recent analysis of common genetic variation associated with BD 
susceptibility using powerful genome-wide approaches, has confirmed that BD is highly 
polygenic in nature with the suggestion that there may be many thousands of common 
variants that contribute small or modest levels of risk for BD6. Thus, for modeling of BD 
with iPSCs choosing individuals at random would make it difficult to identify individuals, 
affected or unaffected, that do not harbor risk alleles, especially common variants associated 
with the disease, and the selection of a genetically appropriate control is problematic. 
Moreover, randomly selected BD patients might also be expected to harbor variants that 
only modestly affect cellular phenotypes in cellular models. Alternatively, consideration of 
family history and the number of risk alleles an individual might harbor (i.e. the genetic 
load) when selecting individuals for reprogramming may allow one to select individuals 
from a pedigree enriched for BD in order to enrich for deleterious alleles. Following this 
rationale, the more psychiatric disease in the family the higher the genetic risk of any 
individual will be, and thus the greater the potential for enrichment of deleterious alleles and 
potentially observable in vitro cellular phenotypes. Furthermore, exploitation of familial 
relationships as part of iPSC model characterization enables the explicit prediction that the 
affected individuals will exhibit phenotypes not found in the unaffected family members. 
This prediction should become increasingly powerful for delineating true disease-specific 
phenotypes from patient-specific phenotypes as size of the family increases.
To begin to explore the potential utility of such a family-based paradigm for iPSC-based 
modeling of BD, which to date has not been applied to any human genetic disorder, here we 
generated and characterized 12 iPSC lines from a family with two unaffected parents and 
two BD male offspring. Overall, while no significant differences were observed between the 
12 iPSCs, upon directed differentiation to the neural lineage our studies revealed several 
neurodevelopmental phenotypes in both BD-patient cells compared to the phenotypes of 
their unaffected parents. Additionally, specific defects in the expression of genes important 
for neurogenesis and neuroplasticity were observed, thereby pointing to new pathways to 
explore in order to understand the neural substrates of BD pathophysiology and providing 
new cellular tools for novel therapeutic discovery.
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METHODS
iPSC derivation and characterization
Fibroblast cell lines GM08330 (unaffected, father), GM08329 (unaffected, mother), 
GM05225 (BD Type I, proband), GM05224 (BD Type I, brother) were obtained from the 
Coriell Cell Repository. Records showed punch biopsies for GM05224 and GM05225 were 
collected from the posterior iliac crest as were the two parents GM08330 and GM08329 (Dr. 
Elliot Gershon, personal communication). Induced pluripotent stem cells (iPSCs) were 
derived using individual pseudotyped retroviruses expressing MYC (MSCV-h-c-MYC-
IRES-GFP, Addgene# 18119), KLF4 (pMIG-hKLF4, Addgene# 17227), SOX2 (pMIG-
hSOX2, Addgene# 17226), and OCT4 (pMIG-hOCT4, Addgene#17225) packaged by 
Harvard Gene Therapy Core (Harvard Medical School) following methods described in29. 
Fibroblasts were infected with all four viruses as described30 and split onto irradiated MEFs 
(GlobalStem, GSC-6301G). Colonies were picked and expanded in hES media on MEFs or 
in mTeSR1 on Matrigel. hES media consisted of 80% DMEM/F12 (Invitrogen, 11320033), 
20% Knock-out Serum Replacement (KOSR) (Invitrogen, 10828-028), 10 ng/mL bFGF 
(R&D systems: Cat# 233-FB-001MG/CF), 1 mM L-glutamine (Invitrogen, 35050-061), 100 
µM non-essential amino acids (Gibco, 11140-050), 100 µM 2-mercaptoethanol (Sigma, 
M6250), 50 U/mL penicillin 50 mg/mL streptomycin (Invitrogen, 15140-122), mTeSR1 
(Stemcell Technologies, 05850).
Karyotyping
Cells were karyotyped by Cell Line Genetics (Madison, WI) with standard Giemsa stained 
chromosome spreads.
Teratoma formation
iPSCs were grown on Matrigel/mTesR1 media. For teratoma formation, ~107 iPSCs were 
pelleted and injected into SCID mice underneath the kidney capsule. Tumors were harvested 
after week 10 and analyzed using standard techniques with interpretation by Frank H. Lau 
(Cowan Lab, HMS, MGH).
Genetic analysis
Genomic DNA was isolated using the DNAEasy kit (Qiagen, 69504). Fingerprinting was 
carried out by the Broad Institute Genomics Platform using the Fluidigm platform according 
to the manufacturer’s instructions. Whole-genome single nucleotide polymorphism (SNP) 
genotyping on 733,202 SNPs was carried out by the Broad Genomics Platform using 
Illumina OmniExpress arrays according to the manufacturer’s instructions.
CNV analysis and validation
CNVs were detected using Birdsuite (version 1.6)31. Events with LOD score >/= 10 kb and 
size >/= 10kb were lifted onto HG19 using the UCSC browser’s lift over tool. These 
spanned ~16 loci. One of these events (HG19:chr6:78973201-79029367) overlaps a region 
of common CNVs in HapMap32. CNVs were validated with either commercially available 
or custom designed TaqMan probes. Probes were - 6p22.1, HG19:chr6:29859709-29896421, 
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Hs03587795_cn (LifeTech), context sequence CAGGAGAATGTTCCTGCTGAGGACA; 
Chr9,HG19:chr9:7734481-7770942, Hs06879643_cn, context sequence 
AATAGCCTCATTACACCTTGCAAAT; 6q16.1, HG19:chr6:95486777-95578465, probe 
primer TCCATAATCAGCGTGGCATA, 5’ 6-FAM ZEN 3’Iowa Black FQ, forward primer 
TCAGGGTTGGTTTGCTTATTG, reverse primer CACCAATATATGTTCAAAGGGTCA. 
Assays were carried out using digital droplet PCR (Bio-Rad) according to the 
manufacturer’s instructions.
Identity-by-descent analysis
Using genotyping data generated by the Illumina Omni Express chip and PLINK33, SNPs 
were pruned using pairwise genotypic correlation to identify informative markers and then 
IBD (Identity-by-Descent) proportions were calculated between all individuals. IBD 
estimates were compared with expected values to affirm relationships between the family 
members34.
Multi-dimensional scaling analysis of SNP genotypes
For multi-dimensional analysis of SNP profiles, Family-811 quartet genotype data was 
merged with data from STEP and HapMap 2, and retained only those genotypes shared 
between all three datasets (N=180,564). Using PLINK35, LD-based SNPs were pruned to 
97,171 SNPs and then multi-dimensional scaling was run. Individuals from CEU (60) 
Western European, YRB (60) Yoruban, HCB (90) Han Chinese, STEP-BP (1753) and 
Family-811 (4) were analyzed.
Isolation of neural progenitor cells (NPCs)
NB/B27/EGF/FGF/Heparin medium (NPC induction media) was Neurobasal media 
(Invitrogen) supplemented with 1× B27 (without retinoic acid) (Invitrogen,12587-010) 1× 
penicillin/streptomycin (Invitrogen,15140-122), 2 mM L-glutamine (Invitrogen, 
21051-024), 20 ng/mL EGF (Sigma-Aldrich, E9644), 20 ng/mL bFGF (R&D systems, 233-
FB-001MG/CF), 5 µg/mL Heparin (Sigma, H3393). NPC maintenance media was knockout 
DMEM/F12 (Invitrogen, 15140-122), 2 mM GlutaMax-1 supplement (Invitrogen, 
35050-061), 1× Antibiotic-antimycotic (Invitrogen, 15240-062), 2% StemPro Neural 
supplement (Invitrogen, A10508-01), 5 µg/mL Heparin (Sigma, H3393), 20 ng/mL bFGF 
(R&D systems: Cat# 233-FB-001MG/CF), 20 ng/mL EGF (Sigma-Aldrich, E9644). Plate 
coating buffer was 15 µg/mL Poly-ornithine (Sigma, P4957), 10 µg/mL Laminin (Sigma, 
L2020). To initially isolate heterogeneous populations of NPCs, iPSC colonies were grown 
on MEFs in hES+bFGF medium. When confluent, colonies were treated with Dispase at 1 
mg/mL and passaged to Matrigel (BD Biosciences, 354277) at approximately 10–20 iPSC 
colonies/well of a 6-well plate and cultured in hES+bFGF media. After 3 days, bFGF was 
withdrawn from the media and iPSCs were allowed to differentiate. Media was changed 
every 2 days. After 7 days, cultures were switched to NPC induction media and changed 
every other day until neural rosettes appeared. Neural rosettes were manually picked and 
transferred to poly-ornithine/laminin coated plates and cultured in NPC media. Cultures 
were fed every other day until confluent. Cells were passaged using TryplE at room 
temperature and plated at a density of 8×104 cells/cm2.
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Fluorescence activated cell sorting of neural progenitors
Conditions and fluorescence activated cell sorting (FACS) parameters were based on work 
of Yuan et al.36. Conjugated antibodies were purchased from BD Biosciences (San Diego): 
CD184-APC (clone 12G5), CD271-PerCPy5.5 (clone C40-1457), CD24-PE (clone ML5), 
CD15-FITC (clone HI98). FACS buffer consisted of 1× Hank’s buffered solution, 2% fetal 
bovine serum, 20 mM glucose, 1× penicillin/streptomycin, 1 mM EDTA and was filtered 
and made fresh for each experiment. Accutase (Invitrogen, A11105-01), DNase I (Sigma, 
D4263), 1 unit /µL, DAPI (Invitrogen, D3571) was made at 2 mg/mL in H2O. To obtain 
CD184+, CD271−, CD24+, CD15+ cells, mixed NPC populations were either 
immunoselected using EasySep CD184 (Stem Cell Technologies) according to the 
manufacturer’s instructions and FACSed or directly FACSed. For preparing cells for FACS, 
0.5–2×107 cells were washed once with DMEM/F12 and dissociated with Accutase at 37°C 
for 5 minutes. FACS buffer was added to terminate digestion and cells were triturated to 
form a single cell suspension. Cells were then washed twice with FACS buffer and 
resuspended at a concentration of 1×107 cells/mL. DNAse I was added to a final 
concentration of 100 units/mL and the suspension was incubated at room temperature for 10 
minutes. Cells were stained immediately. 1×107 cells/mL were stained for 20 minutes at 4°C 
with the respective single conjugated antibodies or all four conjugated antibodies with 
dilutions consisting of 1:12 CD184, 1:20 CD271, 1:12 CD24, and 1:12 CD15. Cells were 
washed once in FACS buffer and resuspended in 500 µL for single color staining and 1–2 
mL for four color staining. Cells were maintained at 4°C until ready for sorting using a 4-
color sorting protocol on a FACS Aria cell sorter to obtain CD184+, CD271−, CD15+, 
CD24+ cells (BD Biosciences). A gating protocol was established in which CD184+ 
CD271− cells were separated into CD24+ and CD15+ containing populations. Cells were 
sorted directly into Neurobasal media at room temperature using a 100 µm nozzle, 20 psi 
sheath pressure, 2,000 events/sec; taking care not to subject the cells to excessive shear 
forces that would reduce viability. Cells were plated with ROCK Inhibitor (10 ng/mL) at a 
concentration of 1–4×105 cells in one well of a six well plate or 0.5 – 0.9 ×105 cells in one 
well of a 12-well plate.
Neuralized embryoid body formation
iPSCs were grown on MEFs or Matrigel to confluence. iPSCs were dissociated with 
Accutase (Invitrogen, A11105-01). 3,000–6,000 single cells were placed in Aggrewell 400 
plates (Stemcell Technologies, 27945) and incubated in hES media without FGF for 24 
hours. Aggregates were released and passed through the 40 µm cell strainer to remove single 
cells. 1,000 aggregates/well were plated in an ultra-low adherence 6-well plate (Corning, 
3471) in Neural Induction medium on day 0. Neuralized embryoid bodies (nEBs) were fed 
every other day and harvested on days one and eleven for further analysis. RNA was 
isolated from EBs using the MicroRNAeasy kit (Qiagen, 217004).
Lineage scorecard analysis
iPSCs were cultured and dissociated as described for nEBs above. nEBs were formed in hES 
media without FGF for 16 days with media changes every two days. nEBs were harvested 
and RNA was collected using a MicroRNAeasy kit (Qiagen, 217004). Lineage scorecard 
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was calculated for nondirected EB differentiation using the NanoString probe set described 
by Bock et al. after quantification using single-molecule imaging on an nCounter System 
according to the manufacturer’s instructions by the Meissner Lab at Harvard University.37
Neuronal differentiation
Cells were dissociated into a single cell suspension with TriplE (Invitrogen, 12604-013) or 
Accutase and 3×104 NPCs were plated on glass coverslips coated with 10 µg/mL laminin 
(Sigma, L2020) and 15 µg/mL poly-ornithine (Sigma, P4957) in Neurobasal media 
(Invitrogen, 21103-049) containing 200 µM ascorbic acid, 0.5 mM dibutyryl cAMP (Sigma, 
D0260), and 1 mg/mL laminin, 20 ng/mL BDNF (Preprotec, 450-02), 20ng/mL GDNF 
(Preprotec, 450-10). Cells were fed every two to three days until ready for immunostaining 
and/or electrophysiology.
Immunostaining
Cells were washed with PBS, fixed in 4% paraformaldehyde at room temperature for 15–20 
minutes and permeablized with 100% ethanol for 2 minutes at room temperature. Fixed cells 
were blocked in 4% BSA, 0.1% Triton X-100, in PBS at room temperature for 1 hour. 
Primary antibodies diluted in 0.5% BSA, 0.1% Triton X-100 in PBS and incubated 
overnight at 4 °C. Following incubation cells were washed 3 times for 5 minutes each in 
PBS then incubated with secondary antibody Alexa-fluor 488-conjugated goat anti-mouse 
antibodies (1:500, Invitrogen A11017), Alexa-fluor 555-conjugated goat anti-rabbit (1:500, 
A21430), Alexa-fluor 647-conjugated goat anti-chicken antibodies (1:500, A21449) for 1 
hour at room temperature. Cells were washed 3 times in PBS and subsequently mounted 
onto glass slides with prolong gold anti-fade reagent with DAPI (Invitrogen, P36931). 
Immunofluorescence was visualized with Nikon Eclipse 80i fluorescent microscope (Nikon, 
Japan). The following primary antibodies were used TuJ1 (anti-β-Tubulin III; 1:500, Sigma 
T2200), MAP2 (1:10000, Chemicon AB5622) and GFAP (1:200, Sigma G3893) (data not 
shown).
NanoString digital mRNA expression profiling
RNA was isolated using the miRNAEasy kit (Qiagen, 217004) according to the 
manufacturer’s instructions. 100 ng of total RNA from each sample was profiled using 
single-molecule imaging on an nCounter System according to the manufacturer’s 
instructions by the Genomics Platform at the Broad Institute using a 352 probe custom 
PsychGene probe set consisting of genes to profile pluripotency, differentiation, WNT 
signaling, and candidate genes previously associated with either BD or schizophrenia (Sup. 
Table 7). Data were normalized using spiked in positive and negative control genes and the 
VSN algorithm38. Differentially expressed genes were identified using the Bioconductor 
module limma39.
RNA-seq transcriptome analysis
RNA was isolated using the miRNAEasy kit (Qiagen, 217004) according to the 
manufacturer’s instructions. All libraries were molecularly barcoded using TruSeq adaptors 
(Illumina) and sequenced on a HiSeq2000 (Illumina) using paired-end 75 cycle reads. The 
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assembly of transcripts estimation of their abundances, and tests for differential expression 
were performed using Tophat (transcriptome version: Ensembl 
Homo_sapiens.GRCh37.73.gtf) and Cufflinks-Cuffdiff v1.040 (transcriptome version: 
Illumina's igenomes Ensembl GRCh37). To increase statistical power, FPKM values were 
averaged from both parental control CXCR4+ NPC samples and both replicates of the BD-
patient CXCR4+ NPCs GM05224. Only transcripts with sufficient read depth in both 
conditions as determined by Cuffdiff analysis were considered in subsequent analysis.
BrdU incorporation assays of DNA replication
Cells were plated on poly-ornithine/laminin coated coverslips and grown for two days. BrdU 
(Sigma, B5002) was added to a final concentration of 10 µM for 2 hours at 37°C. Cells were 
fixed in 2% paraformaldehyde for 15 minutes at room temperature, and then permeablized 
in 95% methanol for 20 min at −20°C. DNA was denatured with 2 N HCl at room 
temperature for 10 minutes, neutralized in 0.1 M borate buffer (pH 8.5) for 10 minutes. Cells 
were blocked in 5% goat serum/0.2% Triton X-100/1% BSA/PBS at room temperature for 
30–60 minutes. Cells were stained with mouse anti-BrdU (1:100, Sigma, B8434) and rabbit 
anti-NESTIN (1:2000, R&D Systems, MAB1259) antibodies. Cells were then stained with 
secondary antibodies goat anti-mouse Alexa 488 and goat anti-rabbit Alexa 555 (Molecular 
Probes Invitrogen, A21428). Coverslips were mounted with Vectashield and imaged. In 3 
independent experiments, 300–500 cells were counted and percent BrdU incorporation was 
calculated as the total BrdU positive cells divided by the total NESTIN positive cells in a 
field. Statistical significance was calculated using ANOVA. CHIR-99021 effects on 
proliferation were measured in parallel cell cultures and were treated with DMSO (vehicle) 
and CHIR-99021 (custom synthesized as for Pan et al.41) at a final concentration of 5 µM 
for 16 hours before BrdU labeling.
Electrophysiology
Cells were differentiated as described above. Standard patch clamp recordings were carried 
out using an extracellular solution (in mM) consisting of 115 NaCl, 2 KCl, 3 CaCl2, 10 
glucose, 1.5 MgCl2 and an intracellular (in mM) consisting of 140 potassium gluconate 
(C6H11KO7), 5 KCl, 2 MgCl2, 10 HEPES, 0.2 EGTA, 2.5 Na-ATP, 0.5 Na-GTP, 10 
Na2phosphocreatine. Voltage activated currents were recorded in the voltage clamp 
configuration using an Axopatch 200B patch clamp amplifier and head stage. Series 
resistance was compensated up to 80%. Action potentials were recorded in the current clamp 
configuration on the Axopatch 200B. Data was acquired using pClamp10 at a rate of 10 kHz 
filtering at 5 Hz. Data was analyzed using pClamp software and custom scripts written in 
Igor (Wavemetrics).
Network analysis, clustering and Gene Ontology analysis
Agglomerative hierarchical clustering with a weighted pair-group average was performed 
using a Pearson correlation coefficient as the similarity metric on the matrix of NanoString 
PsychGene probes that showed statistically significant differential expression in either the 
NPCs or neurons comparing the BD and unaffected parental control samples with XLSTAT 
(v2014.3.02). Disease Association Protein-Protein Link Evaluator (DAPPLE) v2.0 was run 
using the web based tool available at www.broadinstitute.org/mpg/dapple/dappleTMP.php. 
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The resulting direct and indirect network was constructed. Of the input seed list of 53 
differentially expressed genes, 43 were mappable by DAPPLE while a subset of genes that 
were also differentially expressed (C4ORF45, CACNG8, FNIP2, HLA-B, IRX3, NKX2.2, 
NKX6.1, POTED, SOX5, VEPH1) were not. The p-value for the global network parameters 
and individual p-values for seed proteins representing the probability that by chance the seed 
protein would be as connected to other seed proteins (directly or indirectly) as is observed 
were calculated with 5,000 within-degree, node-label permutations. For Gene Ontology 
(GO) analysis of RNA-seq profiles, DAVIDv6.7 bioinformatics software was used to 
determine GO categories with significant representation (p<0.05, Benjamini-Hochberg 
corrected).
Results
We selected a subset of four individuals from a multigenerational kindred, Family-811 with 
bipolar disorder originally described by Gershon and colleague42 (Fig. 1A). This subset, 
referred to here as the “Family-811 quartet”, consisted of an unaffected father (GM08330) 
and mother (GM08329) and their two sons with BD (GM05225 and GM05224) (Fig. 1A; 
Sup. Table 1). Whole-genome SNP profiling of 733,202 markers was performed on 
fibroblast DNA. Analysis of these data using inheritance by descent measures confirmed the 
expected parent-child and sibling relationships of the Family-811 quartet (Fig. 1B; Sup. 
Table 2), and using multi-dimensional scaling analysis showed that the quartet clusters with 
the Northern and Western Europe (CEU) individuals from HapMap (Fig. 1C).
To annotate the genomes of Family-811 quartet with genetic variants of potential relevance 
to neuropsychiatric disorder etiology, we analyzed the whole-genome SNP profiles of the 
Family-811 quartet and confirmed the SNP genotypes of a subset of the peak risk variants 
from the most recent Psychiatric Genetics Consortium GWAS (Sup. Table 3). These 
targeted genotyping assays indicated that all four Family-811 members were homozygous 
reference for the BD risk allele in SYNE1 and ANK3. GM08329 (mother) was heterozygous 
for the risk allele of CACNA1C while the remaining family members were homozygous 
reference for the BD risk allele. All family members in the quartet were heterozygous 
reference for the BD risk allele in ODZ4 (TNM4) except GM05225 who was homozygous 
reference. Finally, all family members were found to be heterozygous reference for a 
ZNF804A schizophrenia risk allele.
Using the whole-genome SNP data, with a criteria of LOD score > 10 and a size > 10 
kilobases31, several copy number variants (CNVs) were identified that segregated from 
parent to offspring (Fig. 1D, E; Sup. Table 4 & 5; Sup. Fig. 1). One CNV greater than 100 
kb was identified in cytoband 9p24.1, near, but not identical, to a region previously 
identified in scans of psychiatric disorder patients by Malhotra et al.43. Three of the CNVs 
(6q16.1, 6q22.1, and 9p24.1) were subsequently validated in DNA isolated from 
lymphoblastoid cell lines from the Familly-811 quartet. Overall, these genomic data are 
consistent with the ethnicity of previous descriptions of members of Family-811, and it 
revealed that the BD patients contained no detectable large (> 10 kb) de novo structural 
genomic variants unique to both BD patients suggesting that CNVs of this nature are 
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unlikely to influence any observed cellular phenotypes unless introduced spontaneously 
during reprograming.
iPSC generation, characterization, and neural differentiation from Family-811
Using classical Yamanaka factors15 (OCT4, SOX2, KLF4 and cMYC) delivered in retroviral 
vectors, at least three iPSC colonies from each fibroblast line from all four Family-811 
quartet members were isolated, expanded, and fully characterized. All 12 iPSC lines were 
picked from primary iPSC colonies prior to any splitting and were expanded separately and 
thus can be considered independent iPSCs lines. Karyotype analysis indicated all 12 iPSCs 
were normal (Sup. Fig. 2), and a 23 SNP marker panel used for fingerprinting iPSCs post-
reprogramming corresponded to their respective parental fibroblast lines (data not shown). 
Pluripotency of all 12 iPSC lines from the quartet was initially assessed through 
measurement of a panel of characteristic pluripotency markers, including NANOG, OCT4, 
SSEA-4, Tra-1-60 and Tra-1-81 (Sup. Fig. 3). As a further test of pluripotency, genome-
wide transcriptome profiles were generated from all 12 iPSCs and PluriTest, a bioinformatic 
assay that uses global gene expression profiles to bench mark unknown iPSCs with bona 
fide pluripotent cells44, was performed. The results of the PluriTest confirmed that the 12 
iPSCs were highly similar in their transcriptome to previously described pluripotent stem 
cells (Sup. Fig. 4). Finally, pluripotency was directly assessed by determining the ability of 
all 12 iPSCs lines to form teratomas in nude mice. Upon sectioning and H&E staining, 
teratomas from all 12 iPSCs were found to contain representative tissue of all three 
(ectoderm, mesoderm, endoderm) germ layers (Sup. Fig. 5). Collectively, these data 
demonstrate successful generation of 12 high-quality, independent iPSC lines (picked from 
unique primary iPSC clones) from a family with BD.
To more specifically investigate the in vitro neural differentiation capacity of each of the 12 
iPSCs lines from the Family-811 quartet, directed neural differentiation was used to generate 
NPCs. To initially derive heterogeneous populations of NPCs containing both central 
nervous system (CNS) and peripheral nervous system (PNS) progenitors, each of the 12 
iPSC lines were cultured individually on MEF feeder cells and colonies were passaged 
manually to feeder-free cultures on Matrigel in the presence of bFGF. After 3 days, bFGF 
was withdrawn to induce differentiation and after 7 days the media was switched to neural 
induction media consisting of Neurobasal media supplemented with B27 (without retinoic 
acid), EGF and bFGF. All 12 of the iPSC lines, regardless of whether they were from the 
healthy control parents or BD sons, were found to be capable of forming neural rosettes with 
a morphology characteristic of early neuroepithelium, which upon picking and expansion on 
poly-ornithine/laminin coated plates gave rise to self-renewing NPCs that stained for a panel 
of markers, including SOX1, SOX2, NESTIN and MUSASHI (Fig. 2A and data not shown).
Next, to create more homogenous populations of NPCs that were enriched for CNS 
progenitors the initially mixed NPC cultures were immunopurified using a four color, 
fluorescence activated cell sorting (FACS) protocol designed to remove non-neural cells and 
cells expressing CD271 (p75; NGFR), a marker of neural crest cells that produce PNS cells 
and select for CD184 (CXC chemokine receptor-4 (CXCR4)) expression as a marker of 
CNS progenitors. (Fig. 2B, Sup. Fig. 6)36. Whereas self-renewing, CD184+/CD271−/
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CD24+/CD15+ cells capable of expansion for more than five passages could be readily 
established from both the mother and father, neural induction of iPSCs from both BD 
patients repeatedly produced more PNS progenitors than CNS progenitors as defined by 
immunostaining for CD271 and CD184 markers, respectively (Sup. Fig. 7). Consistent with 
this phenotype, despite repeated attempts under varied neural induction conditions, CD184+/
CD271−/CD24+/CD15+ immunopurified NPC lines could only be successfully established 
beyond five passages from a subset of the BD-patient iPSC lines. Of the successfully FACS-
purified NPC lines expressing CD184+, all had characteristic NESTIN+ cell morphology, 
proliferated in a monolayer in the presence of EGF and bFGF, and upon mitogen removal 
differentiated into MAP2+ and βIII-tubulin+ (Tuj1+) neurons capable of firing action 
potentials (Fig. 2B, C; Sup. Fig. 8). Thus, as summarized in the lineage diagram shown in 
Figure 2D, we were able to generate expandable (greater than five passages), FACS-
immunopurified, CXCR4+ NPC lines from all six of the parental iPSC lines and only one of 
three iPSC lines from each BD-affected son within the Family-811 quartet.
The successful generation of expandable CXCR4+ NPCs lines from the parental control 
iPSCs and one iPSC from each of the BD-affected sons within the Family-811 quartet 
afforded the opportunity, for the first time, to characterize the molecular and cellular 
phenotypes in a defined CNS progenitor cell (i.e. CXCR4+) and post-mitotic neurons 
derived from them upon neural differentiation. Initially, using bromo-deoxyuridine (BrdU) 
incorporation into DNA to measure cell proliferation, we observed a proliferation deficit in 
both of the BD patient NPCs compared to the unaffected parental NPCs (Fig. 3A, B) (t-test, 
p=0.001). In addition to this proliferation defect, both BD-patient NPCs produced 
qualitatively fewer βIII-tubulin (Tuj1+) neurons than the unaffected NPCs over a six week 
differentiation time course (Fig. 3C). Taken together, these observations, and the difficulty 
encountered in generating CXCR4+ NPCs from neural rosettes by FACS, collectively 
provided initial evidence for a neural differentiation deficit phenotype in both BD-patient 
NPCs from the Family-811 quartet that ultimately negatively impacts ex vivo neurogenesis.
NanoString molecular profiling of iPSCs, NPCs and neurons from Family-811
Having observed a neurogenesis deficit from the BD-patient iPSCs, to ensure that that the 
differentiation deficit did not represent a general differentiation defect of the iPSCs, we 
turned to an evaluation of the overall differentiation capacity of all 12 of iPSCs from the 
Family-811 quartet that we had generated. For these measurements, three independent iPSCs 
lines from each of the unaffected parents (6 lines total) and three independent iPSCs lines 
from the BD sons were grown (6 lines total) for 16 days under non-directed differentiation 
conditions and total RNA was isolated. The expression of a panel of 500 genes designed by 
Bock and colleagues as a “scorecard” to quantitatively define the differentiation capacity of 
human embryonic stem cell (ESCs)/iPSCs of unknown developmental capacity was then 
assessed using NanoString digital mRNA expression profiling technology, a highly 
sensitive, single-molecule imaging of color-coded, molecular barcoded probes (Sup. Table 
6)37. Using this scorecard, we found no correlation between an iPSC line’s ability to 
establish NPCs and its predicted differentiation capacity into ectoderm-derived cell types or 
the expression of a broad set of endodermal and mesodermal markers (Sup. Fig. 9, 10). 
Taken together with the pluripotency marker analysis, teratoma formation assays and 
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PluriTest assay results, these findings on all 12 of the iPSCs indicate that the BD-patient 
iPSCs do not exhibit a general differentiation defect that could otherwise confound the 
interpretation of the deficits in neural differentiation that we observed.
Having established the capacity of all 12 of the Family-811 quartet iPSCs to differentiate 
into multiple cell lineages, we next sought to further establish the nature of the 
neurodevelopmental deficits that were observed. For this, we again isolated total RNA from 
replicate cultures of fibroblasts, iPSCs, CXCR4+ NPCs, and six week differentiated neurons 
from the Family-811 quartet and used NanoString digital mRNA profiling to generate 
molecular signatures of each cell line using a custom “PsychGene” probe set rather than the 
Bock scorecard. This PsychGene probe set was specifically designed to measure the 
expression of 352 genes and consisted of pluripotency genes, neural patterning genes, WNT 
pathway genes and genes implicated in the genetics of neuropsychiatric disorders (Sup. 
Table 7)12,45. Using principle component analysis (PCA) to analyze the global PsychGene 
mRNA signature, we found that the respective cell types clustered together (Fig. 4A). 
Consistent with the results of this global analysis and our previous characterization of the 
iPSC properties, analysis of the expression of pluripotency and neural stem cell markers in 
all 12 iPSC lines confirmed the expected changes in expression of these genes when 
comparing the various cell differentiation states (Fig. 4B).
To better delineate the phenotypic defects in the BD patient cell lines from the Family-811 
quartet, we then examined the average differences in gene expression of the BD patient cells 
relative to the unaffected parental control cells using the PsychGene NanoString probe set. 
Starting with the fibroblasts, examination of volcano plots in which the Log2(fold change) 
was plotted against the −Log10(p-value) revealed that only one gene, ZIC1 (ZIC family 
member 1), a C2H2-type zinc finger transcription factor, met the criteria for a significant 
expression difference (fold change = 13.3, p-value = 0.04, Benjamini-Hochberg corrected) 
(Fig. 4C). For iPSCs, there were no genes that exhibited a significant difference in 
expression between the six control lines and 6 BD patient lines. In sharp contrast to the lack 
of multiple differentially expressed genes in the fibroblasts and iPSC cell states, when 
comparing the expression profiles of the FACS-purified NPCs there were 18 genes with 
significant expression differences between BD-patient NPCs relative to unaffected parental 
control NPCs (> 1.5 fold change; p-value < 0.05, Benjamini-Hochberg corrected) (Fig. 4C; 
Fig. 5A). Amongst this set of differentially expression genes in the BD-patient NPCs were 
three genes encoding homeodomain-containing transcription factors, NKX2-2 (NK2 
homeobox 2), NKX6-1 (NK6 homeobox 1), and IRX3 (iroquois homeobox 3) that are known 
to function in Sonic Hedgehog (SHH)-dependent neural patterning to specify the identity of 
ventral progenitor-derived neurons. In addition several NPC specific genes were 
differentially downregulated in the BD-patient NPCs: PAX6 (paired box gene 6a), DACH1 
(dachshund homolog 1), and PLZF (promyelocytic leukemia zinc finger protein; ZBTB16), 
along with DISC1 (disrupted in schizophrenia 1), the latter of which has been shown to be 
critical for the regulation of neurogenesis and is implicated in the etiology of multiple 
neuropsychiatric disorders9,11,46,47.
To build on the differential gene expression signatures observed in the NPC state, we next 
analyzed the PsychGene NanoString profiles in post-mitotic, neurons that were 
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differentiated for six weeks. As expected, there was an increased expression of the general 
neural differentiation markers DCX (Doublecortin) and MAP2 (Microtubule-associated 
protein 2), as well as expression of multiple markers of upper and lower layer cortical 
projection neurons, including SATB2 (Special AT-rich sequence binding protein 2), CTIP2 
(COUP TF-interacting protein 2; BCL11B), ETV1 (Ets variant gene 1), CUX1 (Cut-like 
homeobox 1), and RELN (Reelin) (Sup. Fig. 11). Comparison of the expression levels in 
BD-patient neurons relative to their unaffected parental controls revealed that 28 genes in 
the PsychGene profiles were upregulated (> 1.5 fold change and p-value < 0.05, Benjamini-
Hochberg corrected), while 16 genes were down regulated (> 1.5 fold change and p-value < 
0.05, Benjamini-Hochberg corrected) (Fig. 4C; Fig. 5B). Given the desire to gain insight 
into specific neuronal subtypes that may underlie alterations in the neurocircuitry affected in 
BD, analysis of the expression of markers of specific neuron subtypes revealed differential 
expression of only the cortical layer maker CTIP2 (BCL11B) and RELN, which were both 
significantly downregulated in the BD-patient neurons compared to neurons from the 
unaffected parents (Fig. 4C; 5B), while numerous other markers of defined neuronal 
subtypes showed no difference (Sup. Fig. 11). In this context, CTIP2 is notable as it is a 
component of the nucleosome remodeling and deacetylation (NuRD) complex48, which 
plays a key role in the epigenetic regulation of neurogenesis49 and the differentiation of 
cortical layer V/VI subcerebral projection neurons50. RELN, an extracellular matrix 
glycoprotein, in contrast, is involved in cortical neuron migration51. Taken together, these 
results provide further support for our hypothesis that differentiation into specific neural 
lineages is disrupted in the BD-patient iPSCs when comparing FACS-purified CXCR4+ 
NPCs.
Having confirmed successful neural differentiation and observed differential gene 
expression amongst the BD-patient CXCR4+ NPCs and neurons relative to unaffected 
parental controls, we sought to link these gene expression differences directly to known 
genetic risk factors neuropsychiatric disorders. To do so, we first analyzed if several genes 
implicated by recent GWAS by the Psychiatric GWAS Consortium52–54, ANK3 (Ankyrin 3), 
CACNA1C (Calcium channel, voltage-dependent, L type, alpha 1C subunit), ODZ4 (Odd 
Oz/ten-m homolog 4) and ZNF804A (Zinc finger protein 804A), were differentially 
expressed in the Family-811 quartet cells. While all four of these genes were expressed and 
exhibited increased expression after six weeks of neural differentiation, none were found to 
be differentially expressed between the BD patient and unaffected parent cells (Sup. Fig. 
12).
Since we noted that a number of the genes were differentially expressed in both BD patients 
CXCR4+ NPCs and their differentiated neuronal progeny, in order to obtain a global view of 
the patterns of gene expression we used agglomerative hierarchical clustering to analyze a 
binary matrix of the total set of 53 significantly dysregulated genes. As shown in Figure 5C, 
a total of eight categories of genes were identified, including those such as SYN1, SCN2A, 
CNTN6, and NKX2.2 that were upregulated in both cell states, as well as genes with opposite 
patterns of expression, such as PAX6, DCX, PLZF that were downregulated in NPCs, but 
upregulated in neurons. Given that the latter three genes are all considered markers of neural 
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progenitors, these data support the notion of the altered neurodevelopment upon directed 
differentiation of BD iPSCs.
Besides differential expression of neurodevelopmental genes, when analyzing the function 
of the other genes in the PsychGene NanoString profiles that showed significant expression 
differences, we noted, that, consistent with prior genetic studies implicating calcium channel 
genes55,56, five of the 34 (~15%) differentially expressed genes in the BD-patient neurons 
were calcium channel or other ion channel subunits (Fig. 5B): CACNA1E (calcium channel, 
voltage-dependent, R type, alpha 1E subunit; Cav2.3), CACNA1G (calcium channel, 
voltage-dependent, T type, alpha 1G subunit; Cav3.1), CACNB1 (calcium channel voltage-
dependent beta 1 subunit), a regulator of alpha-1 subunit membrane targeting and voltage 
dependent activation and inactivation, CACNG8 (calcium channel, voltage-dependent, 
gamma subunit 8), a regulator of AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid) receptor localization, the sodium channel genes SCN2A (sodium 
channel, voltage -gated, type II, alpha subunit; Nav1.2) and SCN3A (sodium channel, 
voltage -gated, type III, alpha subunit; Nav1.3). However, due to the fact that our 
NanoString PsychGene probe set was purposely biased in its construction for coverage of 
genes relevant to neurodevelopment and neuropsychiatric disorder, it was not possible to 
calculate whether there was significant enrichment of any given functional category of genes 
amongst the set of differentially expressed genes.
As an alternative approach to determining if there was evidence for common underlying 
molecular pathways, we turned to the consideration of the protein-protein interaction 
network amongst the proteins encodes by the differentially expressed genes. Using Disease 
Association Protein-Protein Link Evaluator (DAPPLE) v2.0, the set of the 53 differentially 
regulated genes were used as seed nodes and we built a direct and indirect (through other 
proteins) interaction network amongst the proteins encoded by the seed genes with edges 
between the nodes derived from protein-protein interaction data in the InWeb database of 
protein interaction that combines multiple data sources (MINT, BIND, IntAct, KEGG, 
ECrel, Reactome) as described by Lage et al.57 (Sup. Fig. 13A). The statistical significance 
of the connectivity of individual proteins to other seed proteins, as well as a set of network 
connectivity parameters, was then assessed with within-degree, node-label permutation 
methods. Of the input 43 seed genes that could be mapped, 9 proteins (MAP2, GPM6A, 
CACNA1G, CACNA1E, KLF4, CDH2, DACH1, SCN3A, SOX2) showed statistically 
significant (p<0.05) connectivity after a 5,000 within-degree, node-label permutation (Sup. 
Tables 8 & 9). Amongst the direct interactions between seed genes (Sup. Fig. 13B), there 
were 5 protein pairs consisting of: i) PAX6--SOX2; ii) CTIP2--NR2F1; iii) MAPT--NEFM; 
iv) MAP2--CDH2; and v) SCN2A--SNC3A, which was more than expected by chance alone 
(p=0.04, 5,000 permutations). In terms of the global network connectivity parameters, the 
network was composed of a total of 433 interactions from 220 unique proteins. Whereas the 
mean associated protein direct connectivity was not significant, the observed mean 
associated protein indirect connectivity (16.7; p=0.0058, 5,000 permutations) was nearly 
twice that expected. Taken together, these data support the hypothesis that there are shared 
functional pathways that are differentially regulated in the BD patients CXCR4+ NPCs and 
neurons compared to their parental controls. Furthermore, the network analysis points to 
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specific physical protein-protein interaction networks that may be key mediators of the 
underlying phenotypic differences, including the transcription factors PAX6 and SOX2, the 
chromatin regulator CTIP2 and its direct interactor NR2F1 (Nuclear Receptor subfamily 2, 
group F, member 1), a member of the nuclear hormone receptor family of receptors, and the 
calcium channel subunits CACNA1G and CACNA1E.
Global transcriptome analysis of BD patient NPCs versus their parental controls
In order to validate the differential expression of genes in the BD patient-derived cells that 
was observed in the PsychGene NanoString profiles, and in order to specifically characterize 
the BD patient-derived cells in greater depth, we performed genome-wide, transcriptome 
analysis using RNA-sequencing (RNA-seq) to compare the BD patient CXCR4+ NPCs and 
parental control CXCR4+ NPCs since this was the cell state that showed the earliest 
evidence of multiple robust phenotypic differences in the NanoString analysis. Total RNA 
was collected from each of the parental CXCR4+ NPC lines and replicate cultures of one of 
the BD patient CXCR4+ NPCs. Tophat was used to align raw RNA-seq reads to the 
Ensembl human transcriptome followed by Cuffdiff v1.0 identification of differentially 
expressed genes from averaged reads from both parents and averaged reads from both 
replicates of the BD CXCR4+ NPCs. In total, 15,803 transcripts, including both coding and 
non-coding transcripts were measured with sufficient coverage in both samples, of which 
503 were found to have nominally significant differential expression (p<0.05), which after 
correction for multiple hypothesis a total of 35 were considered significantly expressed 
(p<0.05, Benjamini-Hochberg) (Sup. Table 10).
Having these orthogonally generated mRNA quantification data we sought to first cross-
validate these data with our differentially expressed genes observed from the PsychGene 
NanoString molecular profiles of the CXCR4+ NPCs. As summarized in Supplementary 
Figure 14, of the 15 genes analyzable by both methods, we observed concordant results for 
four (80%) of the five upregulated transcripts and six (60%) of the downregulated 
transcripts. Given the vastly different nature of the assays, with discrepancies being possible 
due to differences in transcripts considers and sensitivity of the methods, these results 
overall provide confidence in the reproducibility of the molecular profiles.
Next, to determine whether the set of 503 transcripts covered any significantly 
overrepresented Gene Ontology (GO) terms suggestive of common process and pathways, 
we analyzed the set using DAVIDv6.7 bioinformatics software (Table 1; Sup. Table 11). Of 
the 412 transcripts that could be mapped, 18 GO terms associated with the category of 
Biological Process were found to be significantly overrepresented (>3×; p<0.05, Benjamini-
Hochberg) with the most enriched being those concerning Neuron Differentiation, 
Development, and Morphogenesis. At the same level of enrichment and significance, a total 
of six Cellular Compartment terms were overrepresented, including multiple terms covering 
the extracellular matrix and chromatin. Taken together, these data are overall supportive of 
our conclusions from the molecular profiling using the PsychGene NanoString probe set that 
are differences in expression of genes important for neurodevelopment and neurogenesis in 
the BD patient CXCR4+ NPCs compared to their unaffected parental controls.
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Using the set of 503 nominally significantly, differentially expressed transcripts as input 
seeds, we again constructed a protein-protein interaction network using DAPPLE v2.0 (Sup. 
Fig. 15). Of the input 256 seed genes that could be mapped, 23 proteins showed statistically 
significant (p<0.05) connectivity after a 5,000 within-degree, node-label permutation (Sup. 
Table 12). Amongst the direct interactions between seed genes, there were 113, which was 
more than expected by chance alone as evaluated by permutation testing (p=0.0008). In 
terms of the global network connectivity parameters, the network was composed of a total of 
5,471 interactions between 1,719 unique proteins, with both the observed mean associated 
protein direct connectivity (1.9; p=0.045) and the observed mean associated protein indirect 
connectivity (89.5; p=0.0002) significant with 5,000 permutations (Sup. Fig. 15). Taken 
together with the GO category analysis and similar analysis from using the PsychGene 
NanoString profiles, these data strongly support the hypothesis that there are shared 
functional pathways that are differentially regulated in the BD patients CXCR4+ NPCs 
compared to their parental controls.
Rescue of proliferation defects in BD-patient NPCs with GSK3 inhibition
One gene identified as down regulated in the BD patient CXCR4+ NPCs in the RNA-seq 
profiles that was found to be significantly highly connected (p<0.005; 5,000 permutations) 
within the DAPPLE network was that of Wingless-Type MMTV integration site family, 
member 7B (WNT7B), which had direct interactions with four other seed nodes consisting 
of two members of the frizzled family of seven transmembrane receptors (FZD5, FZD7) and 
two soluble frizzled-related proteins (SFRP1, SFRP2) (Fig. 5E). Collectively, the proteins 
within this module are known to play key roles in the regulation of WNT signaling, which is 
known as critical mediator of neurogenesis, neurodevelopment, and synaptic plasticity. 
Motivated by these observations, the previously observed differential expression of multiple 
WNT pathway components in both the PsychGene NanoString profiles (Fig. 5A, B), along 
with previous implication of WNT/GSK3 signaling in BD in part through the ability of 
lithium to activate WNT signaling12–14, we hypothesized that activation of WNT signaling 
through GSK3 inhibition would be sufficient to rescue the NPC proliferation deficits 
observed in the FACS-purified, BD patient-derived CXCR4+. In agreement with this notion, 
as shown in Figure 5F and Supplemental Figure 16, treatment with CHIR-99021 (5 µM; 16 
hr), a highly selective and potent GSK3 inhibitor41,58, led to a significant increase in BrdU 
incorporation in both BD-patient NPC lines. In parallel, we assessed the response of the 
NPCs to CHIR-99021 treatment at the level of expression of known WNT pathway genes 
using our PsychGene NanoString probe set. As summarized in (Fig. 5G), CHIR-99021 
treatment (5 µM; 16 hr) increased the expression of the β-catenin target genes LEF1 
(Lymphoid enhancer-binding factor 1) and AXIN2 (Axis inhibition protein 2), both of which 
are critical regulators of canonical WNT signaling. Taken together, these results suggest that 
WNT pathway activation can rescue the neurogenesis defects observed in the BD-patient 
CXCR4+ NPCs from the Family-811 quartet.
Gene expression analysis of neutralized embryoid bodies from Family-811 iPSCs
To further corroborate our findings of differential gene expression between the BD patient 
CXCR4+ NPCs and neurons compared to their parental controls, and to overcome the 
limitation of having only one expandable CXCR4+ NPC line from each of the BD patient 
Madison et al. Page 16
Mol Psychiatry. Author manuscript; available in PMC 2015 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
iPSCs, as an alternative differentiation method we turned to the generation of neutralized 
embryoid bodies (nEBs) formed from aggregating iPSCs under conditions that promote 
neuroectoderm formation (Sup. Fig. 17–19). Whole cell RNA was collected from multiple 
BD and unaffected nEBs at day one and day eleven. Using qRT-PCR, as expected, 
neuralization resulted in increased expression of SOX1 (SRY-box containing gene 1), a 
transcription factor that is an early maker of neuroectoderm formation, in both the 
unaffected and BD-patient iPSC lines. In contrast, two of the BD-patient nEBs failed to 
express PAX6, an evolutionarily conserved, homeobox-containing transcription factor 
downstream of SOX1 that plays an essential role in balancing cortical neural progenitor 
proliferation and differentiation59,60, whereas both unaffected parental lines upregulated 
PAX6 expression (Supp. Fig. 17). This downregulation of PAX6 expression in the BD-
patient nEBs was in agreement with the reduced PAX6 expression observed by the 
NanoString profiles in the FACS-isolated CXCR4+ NPCs and by RNA-seq (Fig. 5A; Sup. 
Fig. 14). Taken together, these data suggest the dysregulation of PAX6 expression, a key 
regulator of corticogenesis, contributes to the neural differentiation deficit of the BD patient 
iPSCs from Family-811.
Upon observing aberrant expression of the NPC marker PAX6 in the BD patient nEBs, we 
next tested an expanded set of 48 genes consisting of differentially expressed genes 
identified from our PsychGene NanoString assays of the FACS-purified CXCR4+ NPCs 
along with WNT, NOTCH, and SHH pathway genes using the Fluidigm BioMark HD 
system (Sup. Fig. 18 & 19; Sup. Table 13). As expected, pluripotency genes, SOX2, OCT4 
and NANOG were repressed upon nEB formation to similar extents comparing the BD and 
unaffected parental iPSCs. Significant differential expression of NKX6-1, LEF1, NEUROG1, 
NRG3, and SPARCL1 in the BD nEBs relative to the unaffected parental controls was 
observed (Sup Fig. 18 & 19). Taken together with the results from the analysis of the 
CXCR4+ NPCs using NanoString and RNA-seq, these finding provide further evidence for 
differential gene expression upon induction of neurodevelopment in the BD patient-derived 
cells compared to their parental controls from Family-811.
Discussion
A number of issues inherent to modeling complex, polygenic diseases with patient-derived 
stem cells complicate the unambiguous association of in vitro phenotypes with disease 
pathogenesis. Most notably, given the complex genetic architecture, potential genetic 
diversity of each individual cell line, and also the technical variability in the isolation of 
iPSC lines, the studies performed to date, including those described here, have all been 
underpowered to rigorously test hypotheses about disease etiology and the relationship of 
specific genetic variants to cellular phenotypes.
In this work, we sought to simplify the question of genetic diversity by using genetically 
related individuals rather than genetically unrelated cases and controls under what we 
consider a family-based paradigm for iPSC modeling of complex human genetic disorder. 
To this end, we generated clonally independent iPSCs (rather than clones derived from the 
same founding cell line), as well as highly purified, expandable, CXCR4+ NPCs from 
multiple members of the same family with unaffected and BD individuals. This family-
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based paradigm using a pedigree enriched for neuropsychiatric phenotypes42, has the 
advantage of controlling for genetic background, and enhancing the chance that both 
affected individuals share the same underlying BD etiology. In the future, as higher 
throughput methods for iPSC generation are brought to bear, following such a paradigm will 
allow the field to carry out more adequately powered studies. Given the density of 
psychopathology found within the pedigree of Family-811 from which the nuclear family 
we reprogrammed was derived, a priority for the future should be to reprogram additional 
family members for which fibroblasts already exist in order determine whether other family 
members with BD exhibit the same phenotypes relative to other unaffected family members.
Overall, our phenotypic characterization of the two affected BD sons to their unaffected 
parents at the level of cellular and molecule profiles revealed a number of significant and 
consistent differences (summarized in Sup. Table 14). Given the neurodevelopmental 
phenotypes we observed in the BD iPSCs relative to their parental controls, of paramount 
importance to the interpretation of these results was to demonstrate that the BD iPSCs did 
not exhibit generic differences in their pluripotency and capacity to differentiate into other 
non-neuronal tissues. We addressed this potential concern for all 12 iPSCs lines three ways: 
1) demonstrating the expression of a panel of appropriate pluripotency markers through 
immunostaining and mRNA assays; 2) demonstrating the capacity to form multiple germ 
layers through in vivo teratoma formation; and 3) genome-wide expression profiling and the 
use of PluriTest as a computational method to benchmark our iPSCs to other pluripotent 
stem cells. After first establishing the pluripotency of all three iPSCs generated from each of 
the Family-811 quartet members through multiple methods, and demonstrating a lack of an 
overall differentiation deficit into multiple germ layers, our results point to specific defects 
in this family in the development, establishment or maintenance of NPCs, potentially due to 
the dysregulation of PAX6, an essential regulator of neurogenesis and corticogenesis.
Although the generalizability of these observations will require the creation of iPSCs from 
additional BD patients, which is ongoing, two other studies in the context of psychiatric 
disorders that described the isolation of similar NPCs did not describe phenotypic defects in 
these types of cells25,61. While this manuscript was under revision, a study by Chen et al.62 
described a set of BD patient-derived iPSCs. While Chen et al. did not characterize 
phenotypes of BD NPCs, when differentiated neuronal cells derived from neuronal rosettes 
were examined, encouragingly several gene expression changes that overlap with those 
identified in our iPSC-derived cells from Family-811 were observed. First, PAX6 gene 
expression was altered in both studies: Chen et al. showed PAX6 expression was decreased 
in BD patient neurons; our data suggest PAX6 expression is decreased in BD patient NPCs, 
but in our studies PAX6 expression in the culture was increased upon further differentiation 
into neurons (Fig. 5A, B). While the direction of the PAX6 effect in neurons is different, 
both of these BD iPSC studies are consistent with there being an alteration in the normal fate 
of neuronal differentiation in BD iPSCs. These differences may arise from the use of a 
different neuron/NPC differentiation protocol as in Chen et al., control and BD neurons were 
derived from iPSC aggregates in which neural induction was performed using dual SMAD 
inhibition with subsequent manual passaging and expansion of rosettes followed by 
differentiation into neurons; our NPC derivations begin in a monolayer and did not use dual 
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SMAD inhibition. Alternatively, these differences may be inherent to the particular BD 
patients investigated. Similar to our results, Chen et al. also identified changes in the 
calcium channel subunit CACNA1E, although once again the direction of the change was 
different. Our data also suggest other calcium channel subunits are altered (e.g. CACNA1E, 
CACNA1G, CACNB1, CACNG8 (Fig. 5B)), consistent with calcium signaling being altered 
in neurons from BD patients. Another similarity in the gene expression data were FGF14 
levels: both studies show FGF14 levels are increased in BD neurons. FGF14 is a 
nonsecreted FGF that associates with sodium channel complexes63–66 and regulates their 
function along with the function of presynaptic calcium channels67. Furthermore, FGF14 
localizes at the axonal initial segment (AIS) where Ankyrin G (encoded by ANK3), a BD 
risk gene, clusters sodium channels64,68. Lastly these FGF14/sodium channel complexes 
have been shown to be regulated by GSK369, a target of the BD therapeutic lithium and the 
inhibitor CHIR-99021 used in our study to rescue the proliferation deficit seen in BD patient 
NPCs. While these gene expression data suggest a functional connection between FGF14 
and other BD risk associated genes, there has been to date no significant genetic association 
between FGF14 and bipolar disorder risk in the Psychiatric GWAS consortium’s analysis70. 
Nevertheless, taken together, these consistent gene expression changes and functional 
themes suggest that there may be several connections between genes altered in iPSC-derived 
BD neurons and other risk associated genes and pathways that implicate calcium signaling 
and AIS function as nodes of integration of BD pathogenesis.
Besides the cellular-level phenotypic differences in NPC formation and neurogenesis, at the 
molecular level several groups of differentially expressed genes were observed further 
supporting the notion of neurodevelopmental abnormalities in the BD-patient NPCs and 
neurons. Of note, CNTN6 (Contactin-6; NB-3), a cell adhesion molecule also implicated in 
autism71, which has shown modest association (rs3772277; p = 0.000126) with BD in the 
Psychiatric GWAS Consortium study70, and was significantly associated with a BD 
subgroup with co-morbidities in the GAIN cohort72 (rs2727943; p = 3.3×10−8) was among 
the most differentially expressed genes in both the NanoString and RNA-seq profiling (Fig. 
4C; 5A, B). Previous work suggests that Contactin-6 plays a role in maturation of 
oligodendrocyte progenitors through its interaction with Notch1, a key regulator of 
neurogenesis73, potentially pointing to perturbation of oligodendrocyte development in the 
BD-patient iPSCs. Future studies aimed in investigating whether there are oligodendrocyte 
abnormalities in these and other BD iPSC models is warranted. Finally, several results from 
our studies suggest WNT signaling is perturbed in the neural cells from the two BD affected 
sons. First, in both our NPCs and nEBs, we identified multiple genes involved in WNT 
signaling that were differentially expressed between the BD and parental lines. Second, 
rescue of the proliferation defect in the BD-patient NPCs from Family-811 upon treatment 
with CHIR-99021, a highly potent, and selective GSK3 inhibitor41, suggest dysregulation of 
the WNT pathway may underlie at least a subset of the phenotypic differences observed in 
the BD-patient NPCs. Given the ability of the BD therapeutic lithium to activate WNT 
signaling, these findings support the notion that targeting the WNT/GSK3 pathway may 
provide an important direction for the development of novel therapeutics for BD74.
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In summary, with the generation of this set of 12 iPSCs along with a set of representative 
expandable NPC lines for the first time from a family with BD, our studies have established 
a new paradigm and resource for gaining insight into the etiology and pathogenesis of BD. 
Collectively, our phenotypic comparisons present numerous avenues for future investigation 
through the implication of abnormalities in early steps in NPC formation, WNT/GSK3 
signaling, and ion channels expression in the BD patient-derived NPCs and neurons. Future 
expansion of these studies to include samples from additional families and well phenotyped 
patients along with appropriately selected controls holds tremendous promise for helping 
elucidate fundamental mechanisms of human disease biology and for presenting a new path 
for translating basic research into novel therapeutic discoveries for BD74.
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Figure 1. Genomic characterization of Family-811 quartet
(A) The pedigree for Family-811 is shown. Males are squares and females are circles. 
Affected individuals are shaded while unaffected individuals are open. Individuals from the 
Family-811 quartet studied herein are shown with vermillion squares and circles. The 
associated Coriell identification numbers are shown below the individuals. GM05224 and 
GM05225 were both diagnosed with BD type I. (B) The familial relationship of these 
individuals was confirmed using identity-by-descent (IBD) analysis. The IBD1 and IBD2 
components were plotted for the parent-parent, parent-offspring and offspring-offspring 
comparisons. Each of these comparisons agreed with the theoretic prediction of allele 
sharing for the given familial relationship [(IBD0, IBD1): parent-parent = (1,0), siblings = 
(1/4,1/2), parent-sibling = (0,1)].34 (C) The multidimensional scaling analysis confirmed 
that the Family-811 quartet was ethnically related to the CEU Hap Map population and the 
STEP-BP cohort of individuals used to identify genetically associated bipolar disorder loci. 
Plotted for comparison are HapMap individuals from Northern and Western Europe (CEU), 
Yoruba (YRB), and Han Chinese (HCB). (D) The complement of CNVs identified in the 
Family-811 quartet and their segregation, the size, and encompassed genes. Dark grey 
squares with 2’s indicate a homozygous locus while light grey squares indicate a 
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hemizygous deletion locus, and white squares with a 3 indicate a copy number of 3. The 
pedigree at the top indicates the familial relationship. (E) The orange bars indicate the CNVs 
as determined by SNP analysis, purple bars indicate CNVs identified by droplet digital PCR 
and the green bars are genes identified as RefSeq genes.
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Figure 2. Stepwise neural differentiation of Family-811 quartet iPSCs
(A) Schematic of the two-dimensional iPSC neural induction protocol used. Each of the 
iPSC lines generated from the Family-811 quartet was capable of generating neural rosettes 
with a characteristic morphology that were manually dissected, passaged and expanded in 
culture. Each of the iPSC lines was capable of generating SOX1+ cells that could be 
expanded in vitro. (B) To derive comparable populations of NPCs, a cell surface signature 
described by Yuan et al.36 was used with FACS to isolate CD184+/CD271−/CD24+/CD15+ 
cells. A representative gating scheme and plot of the events for an experiment is shown. 
Representative images of CD184+/CD271−/CD24+/CD15+ cells from GM08330, GM08329, 
GM05225 and GM05224 stained for NESTIN (red) and DAPI (blue) for DNA. (C) FACS-
purified NPCs from the iPSC lines indicated were differentiated into neurons for six weeks 
yielding post-mitotic neurons staining for the neuronal markers TuJ1 and MAP2. (D) A cell 
lineage diagram summarizes the cells and cell lines generated from fibroblasts and iPSCs 
from of each of the individuals in the Family-811 quartet. X’s indicate NPC lines that were 
able to be initally isolated but were unable to be continually expand beyond four or five 
passages in vitro despite mutliple attempts. The scale bar is 100 µm.
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Figure 3. Phenotypic differences of NPCs derived from both BD-patient iPSCs compared to their 
unaffected parents
(A) BrdU incorporation and staining was used to quantify proliferation of the two BD-
patient (GM05225, GM05224) and their unaffected parental (GM08330, GM08329) NPC 
counterparts. (B) Bar graph summarizing the percent of cells of the total NESTIN+ cells that 
incorporated BrdU. The BD-patient NPCs exhibited a significant decrease in BrdU 
incorporation compared to the mean of the unaffected parents (*** indicates significant, t-
test, p=0.001). (C) Upon differentiation, BD-patient NPCs (GM05224-3 NPC and 
GM05225-5 NPC) were found to extend neuritic processes, similar to the unaffected 
counterparts, but exhibited reduced viability after two weeks of differentiation. In the case of 
GM05225-5 almost no neurons remained in culture after six weeks. (D) Higher 
magnification of post-mitotic neurons from the parental control NPC line 8329-1 shown in 
(c). The scale bar is 100 µm. Error bars depict standard deviation of the measurement.
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Figure 4. Differential gene expression signature of BD-patient derived NPCs and neurons
(A) Principle components analysis (PCA) of a custom PsychGene NanoString profiles from 
the Family-811 quartet using all 352 of the genes reveals similar grouping of cells by cell 
type. (B) Fibroblasts, iPSCs and NPCs were compared using probes against OCT4, NANOG, 
SOX2, ZFP42, DNMT3B, hTERT, MYC, GFP with total RNA from the human ES cell line 
H9 shown for comparison. (C) Volcano plots of [−Log10 (p-value) versus the Log2 (fold 
change expression)] of all genes (grey dots). Significant, differentially expressed genes (> 
1.5-fold comparing BD cells to unaffected cells, moderated t-test p-value < 0.05, Benjamini-
Hochberg corrected) were plotted with orange dots with a subset annotated by gene name. 
Those genes that were also significant when members of the Family-811 quartet were 
compared based on sex (i.e. GM08329 versus GM8330, GM05225 and GM05225) were 
colored green. Gene expression differences were found to be enriched in the BD-patient 
NPCs and neuronal populations. Each dot represents a gene expression assay (n=3) for the 
cell type indicated. Error bars depict standard deviation of the measurement.
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Figure 5. Gene expression differences in the BD-patient iPSC neural derivatives
Differential gene expression (>1.5 fold at a significance of p<0.05 calculated using a 
moderated t-test and corrected using the Benjamini-Hochberg test) in (A) BD-patient 
CXCR4+ NPCs and (B) in BD-patient neurons relative to the unaffected parental cells. 
Genes with increased expression are shown in red; genes with deceased expression are 
shown in blue. (C) Agglomerative hierarchical clustering of the 53 differentially expressed 
genes between BD-patient CXCR4+ NPCs and differentiated neurons using a weighted pair-
group average method and a Pearson correlation coefficient as the similarity metric. (D) 
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DAPPLE protein-protein interaction network amongst differentially expressed genes form 
the PsychGene NanoString profiles between BD-patient CXCR4+ NPCs and differentiated 
neurons demonstrating a statistically significant high degree of interconnectivity for specific 
nodes (marked with *) and globally. (E) WNT module within the DAPPLE protein-protein 
interaction network amongst differentially expressed genes from the global RNA-seq 
analysis composed of WNT7B and four additional input seeds amongst the direct 
interactions all of which were downregulated (levels indicated with arrow) in the BD-patient 
CXCR4+ NPCs compared to the parental control CXCR4+ NPCs.
(F) Rescue of DNA synthesis deficits in the BD-patient NPCs with WNT pathway 
activation. BrdU incorporation data with pairs of DMSO and CHIR-99021 treated cell lines 
represented with a symbol connected by a bar. Cell were treated for 16 hours with either 
DMSO (vehicle) or CHIR-99021 (5 µM), labeled with BrdU, fixed, and stained to detect 
BrdU and NESTIN. Proliferation was measured by counting BrdU labeled nuclei and 
quantifying percent of NESTIN+ cells labeled with BrdU. The orange symbol and bars 
represent averages of the BrdU incorporation experiments in the presence of either DMSO 
or CHIR-99021. The proliferation defect observed in the BD-patient CXCR4+ NPCs was 
significantly (pair-wise t-test, p=0.02) decreased with CHIR-99021 treatment while the 
proliferation of the unaffected parental CXCR4+ NPCs was not changed. (G) CHIR-99021 
treatment (16 hours, 5 µM) alters the expression of a subset of WNT pathway responsive 
genes in the BD-patient CXCR4+ NPCs measured using the PsychGene NanoString probe 
set. Several genes were upregulated (> 1.5-fold; p-value <0.05 Benjamini-Hochberg 
corrected) in the BD-patient NPC cell line, including CD44, LEF1, AXIN2 and down 
regulated (GBX2), while others were only responsive in the parental control lines (ATOH, 
GSK3B) unaffected. Error bars depict standard deviation of the measurement.
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